Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis

Jin Wang,Tao Chen,Xiaofan Yu,Nan OUYang,Lirong Tan,Beibei Jia,Jian Tong,Jianxiang Li

DOI: https://doi.org/10.1186/s12967-020-02474-x

IF: 8.44

2020-08-14

Journal of Translational Medicine

Abstract:Abstract Background Lung cancer is one of the most common carcinomas in the world, and lung adenocarcinoma (LUAD) is the most lethal and most common subtype of lung cancer. Cigarette smoking is the most leading risk factor of lung cancer, but it is still unclear how normal lung cells become cancerous in cigarette smokers. This study aims to identify potential smoking-related biomarkers associated with the progression and prognosis of LUAD, as well as their regulation mechanism using an in vitro carcinogenesis model and bioinformatics analysis. Results Based on the integration analysis of four Gene Expression Omnibus (GEO) datasets and our mRNA sequencing analysis, 2 up-regulated and 11 down-regulated genes were identified in both S30 cells and LUAD. By analyzing the LUAD dataset in The Cancer Gene Analysis (TCGA) database, 3 of the 13 genes, viz., glycophorin C ( GYPC ), NME/NM23 nucleoside diphosphate kinase 1 ( NME1 ) and slit guidance ligand 2 ( SLIT2 ), were found to be significantly correlated with LUAD patients’ smoking history. The expression levels of GYPC , NME1 and SLIT2 in S30 cells and lung cancer cell lines were validated by quantitative PCR, immunofluorescence, and western blot assays. Besides, these three genes are associated with tumor invasion depth, and elevated expression of NME1 was correlated with lymph node metastasis. The enrichment analysis suggested that these genes were highly correlated to tumorigenesis and metastasis-related biological processes and pathways. Moreover, the increased expression levels of GYPC and SLIT2 , as well as decreased expression of NME1 were associated with a favorable prognosis in LUAD patients. Furthermore, based on the multi-omics data in the TCGA database, these genes were found to be regulated by DNA methylation. Conclusion In conclusion, our observations indicated that the differential expression of GYPC , NME1 and SLIT2 may be regulated by DNA methylation, and they are associated with cigarette smoke-induced LUAD, as well as serve as prognostic factors in LUAD patients.

medicine, research & experimental

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to identify potential biomarkers for the progression and prognosis of smoking - related lung cancer (especially lung adenocarcinoma, LUAD) and their regulatory mechanisms. Specifically, researchers hope to explore how normal lung cells transform into cancer cells in smokers' bodies through in vitro carcinogenesis models and bioinformatics analysis, and find out the gene changes related to this process. ### Research Background - Lung cancer is one of the most common cancers in the world, and lung adenocarcinoma (LUAD) is the most deadly and common subtype of lung cancer. - Smoking is the main risk factor for lung cancer, but the specific mechanism by which smoking causes normal lung cells to become cancerous is still unclear. ### Research Objectives - Identify potential biomarkers for the progression and prognosis of smoking - related lung adenocarcinoma through in vitro carcinogenesis models and bioinformatics analysis. - Explore the regulatory mechanisms of these biomarkers, especially the impact of DNA methylation on the expression of these genes. ### Main Findings - Through the integrated analysis of four Gene Expression Omnibus (GEO) datasets and mRNA sequencing data, the researchers found 2 up - regulated and 11 down - regulated genes. - Further analysis of the LUAD dataset in the TCGA database found that 3 genes (GYPC, NME1, and SLIT2) were significantly associated with smoking history. - Verified the expression levels of these 3 genes in S30 cells and lung cancer cell lines, and explored their relationships with tumor invasion depth, lymph node metastasis, and prognosis. - Enrichment analysis showed that these genes were highly correlated with biological processes and pathways related to tumorigenesis and metastasis. - Multi - omics data analysis showed that the expression of these genes may be regulated by DNA methylation. ### Conclusions - The research results indicate that the differential expression of GYPC, NME1, and SLIT2 may be regulated by DNA methylation, and these genes are related to smoking - induced lung adenocarcinoma and can be used as prognostic indicators for lung adenocarcinoma patients. ### Keywords - Smoking - Lung adenocarcinoma (LUAD) - DNA methylation - Prognosis - GYPC - NME1 - SLIT2 Through these studies, the author hopes to provide new biomarkers and potential therapeutic targets for the early diagnosis and treatment of smoking - related lung adenocarcinoma.

Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

A Prognostic Risk Model of a Novel Oxidative Stress-Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma.

Identification of Prognostic Biomarkers of Smoking-Related Lung Cancer.

Identification of Genes Associated with Lung Adenocarcinoma Prognosis

Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival

Identifying and assessing a prognostic model based on disulfidptosis-related genes: implications for immune microenvironment and tumor biology in lung adenocarcinoma

Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma

Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer

Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma

Genetic and Microenvironmental Differences in Non-Smoking Lung Adenocarcinoma Patients Compared with Smoking Patients

Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis

Identification of Biomarkers and Molecular Pathways Implicated in Smoking and COVID-19 Associated Lung Cancer Using Bioinformatics and Machine Learning Approaches

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis

Identification of Genes and Analysis of Prognostic Values in Nonsmoking Females with Non-Small Cell Lung Carcinoma by Bioinformatics Analyses